In a Viewpoint article published Dec. 27, 2023, in JAMA Surgery, three Johns Hopkins researchers urge the medical community to dismiss a widely held, but
The FDA is warning consumers not to use counterfeit Ozempic after it found thousands of units of fake product in the supply chain. The agency
The FDA rejected Zealand Pharma’s glucagon receptor agonist in congenital hyperinsulinism (CHI) after identifying problems at a third-party manufacturing site. The company said it remains
Regeneron prevailed in a major patent fight against Mylan, staving off biosimilar competition for its flagship eye drug Eylea for another few years. The big
The following contains links to social media websites including X, TikTok, Instagram, Facebook, and LinkedIn. Emergency department nurse by day, ninja warrior by night? Brittany
Factor XIa inhibitor milvexian did not provide meaningful secondary prevention over dual antiplatelet therapy for stroke survivors, the phase II trial AXIOMATIC-SSP found. In patients
Welcome to MedAI Roundup, highlighting the latest news and research in healthcare-related artificial intelligence each month. Twenty-eight healthcare groups — including CVS Health, Duke Health,
In this interview, Brandon Welch, MS, PhD, founder and CEO of doxy.me, explains why telemedicine is so important in high-conflict environments. Part 1 of this
Gostin and Wetter are experts in health law. Throughout the year, Lawrence O. Gostin, JD, LLD, and Sarah Wetter, JD, MPH, have weighed in on
Amid an ongoing investigation of CAR T-cell therapy safety, the FDA has added risk of secondary malignancies to the boxed warning for ciltacabtagene autoleucel (Carvykti).